Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock

Life Sciences

Volumn 50, Issue 11, 1992, Pages 807-811

  Vadas, P ^c   Scott, K ^b   Smith, G ^a   Rajkovic, I ^b   Stefanski, E ^a   Schouten, B D ^a   Singh, R ^a   Pruzanski, W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Pacific Biotechnology Rushcutters Bay Australia ^*  (Australia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PHOSPHOLIPASE A; PHOSPHOLIPASE A2;

ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; SEPTIC SHOCK; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; IMMUNOREACTIVITY; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PHOSPHOLIPASES A; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SUPPORT, NON-U.S. GOV'T;

EID: 0026610698     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(92)90186-S     Document Type: Article

References (26)

1. Proteinaceous inhibitors of phospholipase A2 purified from inflammatory sites in rats.